Case study: Prescribing GLP-1 agonists for cardiovascular risk reduction
To read the original printed case study, please click here.
Michael J. Blaha, MD, FACC
Director of the Johns Hopkins Cardiometabolic Clinic; Director of Clinical Research, Ciccarone Center for the Prevention of Cardiovascular Disease; and Professor of Medicine, Johns Hopkins
Copyright 2022 Health Monitor Network. All Rights Reserved.